More than 260 European drug policy NGOs and 130 drug policy experts from 25 EU Member States have already signed the 2024 Manifesto for a progressive EU drug policy.
TEDI find consistent adulteration and risk trends across Europe's drug market since 2018, and call for more resources to improve market monitoring and harm reduction.
Stronger cooperation with civil society is essential to ensure the European Drugs Agency continues to prioritise health, social justice and human rights.
The EU Civil Society Forum on Drugs discusses decriminalisation, focusing on members' perspectives and noting how this framework could contribute to the EU's commitment to balanced, human-rights based approach.
Youth RISE, SSDP International and Young Wave present a sustainability framework to develop skills, knowledge, network and strategies for young people in drug-related organisations internationally.
The BOOST project seeks to combat HIV/AIDS and viral hepatitis in Europe through community-led harm reduction initiatives, aiming to enhance health services for people who use drugs and marginalised populations.
Uneven progress has been seen in deaths among people with HIV, as people who inject drugs, women and the most marginalised in society continue to face vulnerability to premature death.
Over 30 European organisations acknowledge the failure of drug policies and demand a new approach prioritising health, rights, and community participation
TEDI provide accessible interactive maps with data on geographical and temporal patterns, covering various substances, supporting people navigating a volatile supply and providing insights into key drug market trends.
Cancer patients, people suffering from post-traumatic disorder, and wounded soldiers poised to benefit after Ukraine parliament passes historic law on medical cannabis